Lower frequency routine surveillance endomyocardial biopsies after heart transplantation.

In heart transplantation (HTx) patients, routine surveillance endomyocardial biopsies (rsEMB) are recommended for the detection of early cardiac allograft rejection. However, there is no consensus on the optimal frequency of rsEMB. Frequent rsEMB have shown a low diagnostic yield in the new era of p...

Full description

Bibliographic Details
Main Authors: Ludwig T Weckbach, Ulrich Maurer, Rene Schramm, Bruno C Huber, Korbinian Lackermair, Max Weiss, Bruno Meiser, Christian Hagl, Steffen Massberg, Sandra Eifert, Ulrich Grabmaier
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5571958?pdf=render
id doaj-c5f45d438f264a12bce5097eb17034ef
record_format Article
spelling doaj-c5f45d438f264a12bce5097eb17034ef2020-11-25T00:27:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018288010.1371/journal.pone.0182880Lower frequency routine surveillance endomyocardial biopsies after heart transplantation.Ludwig T WeckbachUlrich MaurerRene SchrammBruno C HuberKorbinian LackermairMax WeissBruno MeiserChristian HaglSteffen MassbergSandra EifertUlrich GrabmaierIn heart transplantation (HTx) patients, routine surveillance endomyocardial biopsies (rsEMB) are recommended for the detection of early cardiac allograft rejection. However, there is no consensus on the optimal frequency of rsEMB. Frequent rsEMB have shown a low diagnostic yield in the new era of potent immunosuppressive regimen. Efficacy and safety of lower frequency rsEMB have not been investigated so far. In this retrospective, single centre, observational study we evaluated 282 patients transplanted between 2004 and 2014. 218 of these patients were investigated by rsEMB and symptom-triggered EMB (stEMB). We evaluated EMB results, complications, risk factors for rejection, survival 1 and 5 years as well as incidence of cardiac allograft vasculopathy (CAV) 3 years after HTx. A mean of 7.1 ± 2.5 rsEMB were conducted per patient within the first year after HTx identifying 7 patients with asymptomatic and 9 patients with symptomatic acute rejection requiring glucocorticoide pulse therapy. Despite this relatively low frequency of rsEMB, only 6 unscheduled stEMB were required in the first year after HTx leading to 2 additional treatments. In 6 deaths among all 282 patients (2.1%), acute rejection could not be ruled out as a potential underlying cause. Overall survival at 1 year was 78.7% and 5-year survival was 74%. Incidence of CAV was 17% at 3-year follow-up. Morbidity and mortality of lower frequency rsEMB are comparable with data from the International Society for Heart and Lung Transplantation (ISHLT) registry. Consensus is needed on the optimal frequency of EMB.http://europepmc.org/articles/PMC5571958?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ludwig T Weckbach
Ulrich Maurer
Rene Schramm
Bruno C Huber
Korbinian Lackermair
Max Weiss
Bruno Meiser
Christian Hagl
Steffen Massberg
Sandra Eifert
Ulrich Grabmaier
spellingShingle Ludwig T Weckbach
Ulrich Maurer
Rene Schramm
Bruno C Huber
Korbinian Lackermair
Max Weiss
Bruno Meiser
Christian Hagl
Steffen Massberg
Sandra Eifert
Ulrich Grabmaier
Lower frequency routine surveillance endomyocardial biopsies after heart transplantation.
PLoS ONE
author_facet Ludwig T Weckbach
Ulrich Maurer
Rene Schramm
Bruno C Huber
Korbinian Lackermair
Max Weiss
Bruno Meiser
Christian Hagl
Steffen Massberg
Sandra Eifert
Ulrich Grabmaier
author_sort Ludwig T Weckbach
title Lower frequency routine surveillance endomyocardial biopsies after heart transplantation.
title_short Lower frequency routine surveillance endomyocardial biopsies after heart transplantation.
title_full Lower frequency routine surveillance endomyocardial biopsies after heart transplantation.
title_fullStr Lower frequency routine surveillance endomyocardial biopsies after heart transplantation.
title_full_unstemmed Lower frequency routine surveillance endomyocardial biopsies after heart transplantation.
title_sort lower frequency routine surveillance endomyocardial biopsies after heart transplantation.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description In heart transplantation (HTx) patients, routine surveillance endomyocardial biopsies (rsEMB) are recommended for the detection of early cardiac allograft rejection. However, there is no consensus on the optimal frequency of rsEMB. Frequent rsEMB have shown a low diagnostic yield in the new era of potent immunosuppressive regimen. Efficacy and safety of lower frequency rsEMB have not been investigated so far. In this retrospective, single centre, observational study we evaluated 282 patients transplanted between 2004 and 2014. 218 of these patients were investigated by rsEMB and symptom-triggered EMB (stEMB). We evaluated EMB results, complications, risk factors for rejection, survival 1 and 5 years as well as incidence of cardiac allograft vasculopathy (CAV) 3 years after HTx. A mean of 7.1 ± 2.5 rsEMB were conducted per patient within the first year after HTx identifying 7 patients with asymptomatic and 9 patients with symptomatic acute rejection requiring glucocorticoide pulse therapy. Despite this relatively low frequency of rsEMB, only 6 unscheduled stEMB were required in the first year after HTx leading to 2 additional treatments. In 6 deaths among all 282 patients (2.1%), acute rejection could not be ruled out as a potential underlying cause. Overall survival at 1 year was 78.7% and 5-year survival was 74%. Incidence of CAV was 17% at 3-year follow-up. Morbidity and mortality of lower frequency rsEMB are comparable with data from the International Society for Heart and Lung Transplantation (ISHLT) registry. Consensus is needed on the optimal frequency of EMB.
url http://europepmc.org/articles/PMC5571958?pdf=render
work_keys_str_mv AT ludwigtweckbach lowerfrequencyroutinesurveillanceendomyocardialbiopsiesafterhearttransplantation
AT ulrichmaurer lowerfrequencyroutinesurveillanceendomyocardialbiopsiesafterhearttransplantation
AT reneschramm lowerfrequencyroutinesurveillanceendomyocardialbiopsiesafterhearttransplantation
AT brunochuber lowerfrequencyroutinesurveillanceendomyocardialbiopsiesafterhearttransplantation
AT korbinianlackermair lowerfrequencyroutinesurveillanceendomyocardialbiopsiesafterhearttransplantation
AT maxweiss lowerfrequencyroutinesurveillanceendomyocardialbiopsiesafterhearttransplantation
AT brunomeiser lowerfrequencyroutinesurveillanceendomyocardialbiopsiesafterhearttransplantation
AT christianhagl lowerfrequencyroutinesurveillanceendomyocardialbiopsiesafterhearttransplantation
AT steffenmassberg lowerfrequencyroutinesurveillanceendomyocardialbiopsiesafterhearttransplantation
AT sandraeifert lowerfrequencyroutinesurveillanceendomyocardialbiopsiesafterhearttransplantation
AT ulrichgrabmaier lowerfrequencyroutinesurveillanceendomyocardialbiopsiesafterhearttransplantation
_version_ 1725341329118986240